Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.
Hosoya K, Komachi T, Masaki K, Suzaki I, Saeki H, Kanda N, Nozaki M, Kamide Y, Matsuwaki Y, Kobayashi Y, Ogino E, Osada SI, Usukura N, Kurumagawa T, Ninomia J, Asako M, Nakamoto K, Yokoi H, Ohyama M, Tanese K, Kanzaki S, Fukunaga K, Ebisawa M, Okubo K.
Hosoya K, et al. Among authors: komachi t.
Patient Prefer Adherence. 2023 Mar 27;17:861-872. doi: 10.2147/PPA.S389865. eCollection 2023.
Patient Prefer Adherence. 2023.
PMID: 37009430
Free PMC article.